KCNA3 抗体
KCNA3 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1D8 unconjugated
KCNA3 适用: 人, 小鼠, 大鼠 WB, IHC, IF, ICC, FACS, IP, LCI 宿主: 兔 Polyclonal unconjugated
KCNA3 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
KCNA3 抗体 by 适用
Find KCNA3 抗体 for a variety of species such as anti-Human KCNA3, anti-Rat KCNA3, anti-Mouse KCNA3. The species listed below are among those available. Click on a link to go to the corresponding products.
KCNA3 抗体 by 抗体来源
Find KCNA3 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
KCNA3 抗体 by 克隆形成能力
Find available monoclonal or polyclonal KCNA3 抗体. Click on a link to go to the corresponding products.
KCNA3 抗体 by 克隆
Find KCNA3 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular KCNA3 抗体
- (5)
- (5)
- (2)
- (2)
- (3)
- (3)
- (1)
- (1)
- (1)
- (2)
- (2)
Latest Publications for our KCNA3 抗体
: "K+ channels expression in hypertension after arterial injury, and effect of selective Kv1.3 blockade with PAP-1 on intimal hyperplasia formation." in: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, Vol. 28, Issue 6, pp. 501-11, (2014) (PubMed).: "Blockade of Kv1.3 channels ameliorates radiation-induced brain injury." in: Neuro-oncology, Vol. 16, Issue 4, pp. 528-39, (2014) (PubMed).
: "Somatodendritic ion channel expression in substantia nigra pars compacta dopaminergic neurons across postnatal development." in: Journal of neuroscience research, Vol. 92, Issue 8, pp. 981-99, (2014) (PubMed).
: "Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model." in: Journal of autoimmunity, Vol. 55, pp. 63-72, (2014) (PubMed).
: "Novel objective classification of reactive microglia following hypoglossal axotomy using hierarchical cluster analysis." in: The Journal of comparative neurology, Vol. 521, Issue 5, pp. 1184-201, (2013) (PubMed).
: "A defined heteromeric KV1 channel stabilizes the intrinsic pacemaking and regulates the output of deep cerebellar nuclear neurons to thalamic targets." in: The Journal of physiology, Vol. 591, Issue Pt 7, pp. 1771-91, (2013) (PubMed).
: "Expression of Kv1.3 potassium channels regulates density of cortical interneurons." in: Developmental neurobiology, Vol. 73, Issue 11, pp. 841-55, (2013) (PubMed).
: "Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle." in: The journal of physiological sciences : JPS, Vol. 64, Issue 1, pp. 13-20, (2013) (PubMed).
: "Increased Kv1 channel expression may contribute to decreased sIPSC frequency following chronic inhibition of NR2B-containing NMDAR." in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 37, Issue 6, pp. 1338-56, (2012) (PubMed).
: "N-glycosylation promotes the cell surface expression of Kv1.3 potassium channels." in: The FEBS journal, Vol. 279, Issue 15, pp. 2632-44, (2012) (PubMed).
Aliases for KCNA3 抗体
potassium voltage-gated channel subfamily A member 3 (KCNA3) 抗体potassium channel, voltage gated shaker related subfamily A, member 3 S homeolog (kcna3.S) 抗体
potassium voltage-gated channel, shaker-related subfamily, member 3 (Kcna3) 抗体
potassium voltage-gated channel subfamily A member 3 (Kcna3) 抗体
cKv1.1 抗体
HGK5 抗体
HLK3 抗体
HPCN3 抗体
HUKIII 抗体
Kca1-3 抗体
kcna3b-a 抗体
kv1.3 抗体
KV1.3 抗体
Kv1.3 抗体
Kv1.3-glyb 抗体
Kv1.3B 抗体
Mk-3 抗体
MK3 抗体
PCN3 抗体